VaccinesJul 27, 2026

Possible Ways mRNA in Lipid Nanoparticles Breaks Down: A Complete Review

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Jul 28, 2026

Abstract

Messenger RNA-lipid nanoparticle (mRNA-LNP) formulations are highly sensitive to various physicochemical factors that may compromise their stability.

Instability in mRNA-LNP products is influenced by factors such as temperature, pH, light exposure, oxidation, aggregation, shear stress, and humidity.
These destabilizing factors can lead to a decrease in vaccine potency and may increase the risk of adverse safety outcomes.
Understanding the mechanisms behind these stability challenges is essential for maintaining the efficacy of mRNA-LNP formulations.
The review outlines key instability factors and degradation mechanisms affecting mRNA and lipid nanoparticle components.
Stabilization strategies and analytical methods for detecting and quantifying degradation in mRNA-LNP products are also summarized.

Simplified

Messenger RNA-lipid nanoparticle (mRNA-LNP)-based drug products represent a promising platform for prophylactic and therapeutic applications. However, their limited stability poses significant challenges for storage and global distribution. The instability of mRNA-LNP products makes them dependent on ultra-cold chain systems. This instability is driven by various physicochemical factors, including temperature, pH, light exposure, oxidation, aggregation, shear stress, and humidity. These factors destabilize the physical and chemical integrity of both mRNA and lipid nanoparticle (LNP) components, leading to reduced vaccine potency and potentially increasing the risk of adverse safety outcomes. Understanding these factors and their mechanisms is crucial for retaining mRNA-LNP efficacy. This review discusses the key physicochemical instability factors and molecular degradation mechanisms responsible for the structural and functional deterioration of mRNA-LNP formulations. Further, we summarize the stabilization strategies and analytical methods used to detect and quantify the degradation of mRNA-LNP products. Addressing these challenges is critical for advancing next-generation nucleic acid-based drug products and LNP-based delivery systems.

Full Text

Full text is available at the source.

View Full Text ↗

Possible Ways mRNA in Lipid Nanoparticles Breaks Down: A Complete Review

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief